News

Featured News

  • 2022 |
  • 2021 |
  • 2020 |
  • 2019 |
  • 2018 |
  • 2017 |
  • View All
  • News | October 20, 2021

    imCheck Publishes Comprehensive Overview of the Developmenet Resumts of its First-in-class Cancer Immunotherapeutic Targeting BTN3A to Activate Cells in Science Translational Medicine

    Read More

    Press Release | October 18, 2021

    Dragonfly Therapeutics Announces Sixth Dragonfly Drug to be Licensed by Bristol Myers Squibb and Receipt of Milestone Payments Following First Patient Dosing of Two TriNKETâ„¢ Immunotherapies

    Read More

    Press Release | October 13, 2021

    Agent Capital Adds Dr. John Orloff as Venture Partner

    Read More

    Press Release | October 11, 2021

    Pyxis IPO leads way as four life science firms kick off 4Q, raising nearly $500M

    Read More